XML 40 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2016
Accounting Policies [Abstract]  
Summarized Unaudited Financial Information for the Equity Method Investments
Summarized unaudited financial data as of September 30, 2016 and December 31, 2015 and for the three and nine months ended September 30, 2016 and 2015, for the Company's equity method investments are shown in the following tables. Summarized unaudited financial data for ZIOPHARM has been included through June 30, 2015 for the nine months ended September 30, 2015 as the Company determined it had significant influence over ZIOPHARM until the Company distributed its investment in ZIOPHARM to shareholders in June 2015.
 
September 30,
2016
 
December 31,
2015
Current assets
$
81,049

 
$
28,123

Non-current assets
10,992

 
1,539

Total assets
92,041

 
29,662

Current liabilities
8,325

 
6,274

Net assets
$
83,716

 
$
23,388


 
Three Months Ended 
 September 30,
 
Nine Months Ended 
 September 30,
 
2016
 
2015
 
2016
 
2015
Revenues
$
65

 
$
330

 
$
394

 
$
1,480

Operating expenses
18,363

 
8,687

 
50,406

 
118,180

Operating loss
(18,298
)
 
(8,357
)
 
(50,012
)
 
(116,700
)
Other
75

 
(34
)
 
1,502

 
(31
)
Net loss
$
(18,223
)
 
$
(8,391
)
 
$
(48,510
)
 
$
(116,731
)